Unveiling the Secret Sauce: The Microbiome Science Company’s Bold Move Into Vaginal Health

In the world of women’s health, maintaining a balanced vaginal microbiome is key to overall well-being. Enter Seed, a microbiome science company that is revolutionizing the game with the launch of a groundbreaking vaginal suppository. This innovative product is designed to help women achieve a more stable vaginal microbiome, addressing a critical need in the market that has long been overlooked.

Developed in collaboration with Dr. Jacques Ravel, a renowned expert in vaginal microbiome research, Seed’s new vaginal suppository focuses on three strains of Lactobacillus crispatus. After more than 15 years of dedicated research in the field, Dr. Ravel identified a gap in effective solutions for women’s health, particularly when it comes to maintaining a healthy vaginal microbiome. While antibiotics may combat pathogens, they can also disrupt the delicate balance of the vaginal microbiome, leading to recurrent infections.

Unlike traditional vaginal probiotics that are designed for oral consumption, Seed’s VS-01™ suppository delivers targeted support directly to the source. By harnessing the power of three proprietary strains of L. crispatus, this innovative product has been clinically proven to restore and maintain a healthy vaginal microbiome. In fact, 90 percent of participants experienced an optimal vaginal microbiome dominated by L. crispatus within just 21 days of use, showcasing the efficacy of this groundbreaking solution.

Common factors such as sexual activity, swimming, exercise, and menstruation can all contribute to fluctuations in the vaginal microbiome. Seed’s VS-01™ suppository offers a unique approach to promoting vaginal health by providing a direct and effective means of delivering beneficial probiotics to the vaginal environment. This targeted delivery system sets Seed apart from other products on the market, offering women a new level of care and empowerment over their own bodies.

While vaginal suppositories with probiotics are not entirely new, Seed’s focus on specific strains of L. crispatus sets it apart as a trailblazer in the field. With a deep commitment to women’s health and a dedication to advancing the understanding of the vaginal microbiome, Seed’s collaboration with Dr. Ravel represents a significant step forward in the quest for innovative solutions in women’s wellness. As co-founder Ara Katz aptly puts it, “The vaginal microbiome is the next frontier in women’s health, and VS-01™ embodies its vast potential—an entirely new paradigm of care that empowers greater agency over our bodies.”